Bionomics Limited (NASDAQ:BNOX) Short Interest Update

Bionomics Limited (NASDAQ:BNOX) was the recipient of a significant drop in short interest during the month of July. As of July 15th, there was short interest totalling 148,600 shares, a drop of 24.9% from the June 30th total of 198,000 shares. Based on an average daily trading volume, of 525,900 shares, the short-interest ratio is presently 0.3 days.

Bionomics Trading Down 1.1 %

Shares of BNOX stock traded down $0.01 on Monday, reaching $0.67. The company’s stock had a trading volume of 64,168 shares, compared to its average volume of 346,827. The stock’s fifty day simple moving average is $0.79 and its 200-day simple moving average is $0.95. Bionomics has a 1 year low of $0.65 and a 1 year high of $6.41.

Wall Street Analysts Forecast Growth

Separately, HC Wainwright reissued a “buy” rating and issued a $8.00 target price on shares of Bionomics in a report on Thursday, July 18th.

About Bionomics

Bionomics Limited, a clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers. The company's lead drug candidate includes BNC210, a negative allosteric modulator of the a7 nicotinic acetylcholine receptor, which is in phase 2 clinical trial for the treatment of social anxiety disorder and phase 2b to treat post-traumatic stress disorder.